Brain Monitoring Devices Market
Brain Monitoring Devices Market Analysis By Product (Devices, Accessories), By Disease (Traumatic Brain Injuries, Parkinson`s Disease, Sleep Disorders, Epilepsy, Huntington`s Disease), By End User (Hospitals, Clinics, Ambulatory Surgery Centers), & By Region - Global Market Insights 2022 to 2027
Analysis of Brain Monitoring Devices market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Brain Monitoring Devices Market Outlook (2022 to 2027)
The global brain monitoring devices market is currently valued at US$ 6.5 billion and is expected to increase at a noteworthy CAGR of 6% to reach US$ 8.7 billion by the end of 2027.
The devices segment of the market is expected to progress at a similar CAGR of 6% from 2022 to 2027 and reach a market valuation of around US$ 7 billion by 2027.
| Report Attributes | Details |
|---|---|
| Brain Monitoring Devices Market Size (2022E) | US$ 6.5 Billion |
| Forecasted Market Value (2027F) | US$ 8.7 Billion |
| Global Market Growth Rate (2022 to 2027) | 6% CAGR |
| China Market Value (2027) | US$ 2 Billion |
| Key Companies Profiled | Advanced Brain Monitoring; B. Braun Medical BD; Cadwell Industries Inc.; CAS Medical Systems Inc.; Compumedics Limited; DePuy Synthes Companies; Electrical Geodesics Inc; Elekta AB; EMOTIV Inc.; General Electric; Integra LifeSciences Corporation; Koninklijke Philips N.; Masimo Corporation; Medtronic; Natus Medical Incorporated; NIHON KOHDEN CORPORATION; Rimed Inc.; Siemens Healthcare Private Limited; Yokogawa Electric Corporation |
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Revenue Analysis of Brain Monitoring Devices (2017 to 2021) Vs. Market Forecasts (2022 to 2027)
In neurological testing, brain monitoring systems are used to identify any abnormalities in the way that brain cells (neurons) work that can result in the emergence of neurological illnesses such as Parkinson's disease, dementia, epilepsy, sleep disorders, and Alzheimer's. Without invasive neurosurgery, these technologies enable the observation and detection of neuronal activity.
Using an intracranial pressure monitoring device, doctors can determine whether one's symptoms are being brought on by high or low cerebrospinal fluid (CSF) pressure. A tiny pressure-sensitive probe that is put through the skull during the examination directly detects the pressure within your brain.
To offer more metrics for clinical decision-making and therapy augmentation, brain tissue oxygen monitoring systems are used for monitoring both oxygen and temperature in the cerebral cavity.
These systems keep an eye on indicators such as neural activity, pressure around the brain, cerebral oxygenation capacity, strokes, traumatic cranial damage, blood pressure, and other dangerous situations. The global brain monitoring devices market has seen a growth in demand for non-invasive brain monitoring technologies including MRI, EEG, MEG, and more.
Systems for monitoring the brain are an essential component of radiographic and neuroimaging operations.
According to market dynamics derived from disease epidemiology and procedure adoption rates, several macroeconomic and industrial factors, including device regulations, device safety, and device licensing, may influence demand for brain monitoring devices.
Considering the above factors the market for brain monitoring devices is expected to progress at a healthy growth rate.
According to Fact.MR, a market research and competitive intelligence provider, over the next five years, the global brain monitoring devices market is expected to expand at a CAGR of 6% and reach US$ 8.7 billion by 2027.
What is Driving the Market Share of Brain Monitoring Systems?
“Rising Global Incidence & Prevalence of Neurological Disorders”
Dementia, epilepsy, Parkinson's disease, headache disorders, Huntington's disease, neuro infections, multiple sclerosis, stroke, and cerebral palsy have all seen considerable increases in their incidence and prevalence around the world over time.
Brain disorders, which encompass a variety of psychiatric, neurodegenerative, and developmental illnesses, are a rising source of morbidity around the world. This can primarily be contributed to the rising rate of the elderly population.
- The American Medical Association (AMA) predicts that by 2030, at least 60% of people 65 years of age and older will be living with multiple chronic conditions.
The following list includes some significant data on the incidence and prevalence of neurological disorders:
According to a WHO report published on 2nd September 2021,
- Almost 10 million new cases of dementia are diagnosed each year, and there are already over 55 million people living with this disease worldwide.
- Many illnesses and injuries that directly or indirectly impact the brain can lead to dementia. The most prevalent type of dementia, Alzheimer's disease may be a factor in 60-70% of cases.
According to a WHO report published on 9th February 2022,
- Epilepsy affects about 50 million individuals worldwide, making it one of the most prevalent neurological conditions globally.
- Nearly 80% of epilepsy patients reside in low- and middle-income nations.
It is crucial to keep an eye on the brain and neurological processes given the prevalence of certain neurological illnesses. Risk of many degenerative neurological diseases and illnesses rises with age.
Other illnesses and problems, such as sickle-cell diseases and heart disorders, are also becoming more common. Another significant reason influencing demand for brain monitoring equipment is the potential impact of cardiac procedures on the brain's normal function.
“Sensors for Brain Monitoring Widely Being Used in Advanced Integrated Healthcare”
During the bidirectional data collection and processing of EEG signals, brain monitoring sensors assist clinicians in keeping track of the brain when it is under the influence of anaesthesia.
Monitoring patients with severe brain injuries are becoming increasingly important to stop further brain damage, especially cerebral ischemia. Demand for brain monitoring sensors will be driven by the rising need for measuring elevated intracranial pressure (ICP) in patient monitoring.
Because it involves coming into contact with the sensitive brain tissue directly, invasive monitoring is a difficult, uncomfortable, and dangerous process. As a result, the use of non-invasive or minimally-invasive brain monitoring technology is welcomed by both medical professionals and patients.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
How are Sales of Brain Monitoring Devices Being Adversely Affected?
“High Cost of Brain Monitoring Equipment Production & Maintenance, As Well As High Diagnose Cost”
One of the main factors limiting global sales of brain monitoring devices is its high cost, particularly in developing nations with weak reimbursement regulations. Brain monitoring technologies are quite technical, and the process required to use them are typically expensive.
For example, an EEG costs roughly between US$ 200 - US$ 700; however, extended monitoring might increase the price to US$ 3,000. An ICP monitor costs about US$ 340 - US$500, and a dual-channel TCD costs about US$ 3,200.
Similarly, a single MEG system use costs between US$ 2.5 million to US$ 3 million. Healthcare providers find it difficult to obtain MEG devices due to their high cost, even in countries where high-tech medical technology is widely utilized.
The total cost of ownership of these gadgets rises due to the maintenance costs and other related indirect costs, which limits their adoption.
Due to financial limitations, small hospitals and independent ambulatory surgery centers are also less likely to purchase expensive and complex equipment; this is more noticeable in developing nations.
As these operations are expensive and poorly reimbursed, only a small number of patients in underdeveloped nations can afford neurological treatments. As a result, medical facilities may avoid spending money on novel or cutting-edge technology, which restricts the market for brain monitoring machines.
How are Innovations in Brain Monitoring Systems Helping New Market Players?
“Advancements in Brain Monitoring Systems - The Way to Go for New Companies”
Devices that diagnose without the need for cables or cords are called wireless monitors. Wireless headphones make it possible for patients to be examined from the convenience of their own homes while completely taking non-invasive readings.
Due to invent of wireless technology, the recording equipment can be removed from the computer and communicate with it wirelessly being up to 10 or 20 metres away. These gadgets only need one AAA battery and are simple to maintain, cheap, and simple to use. Portable brain monitoring machines are compact, lightweight, and easy to hold in the hand.
Such advanced brain monitoring products help to make the treatment process easy for both doctors and patients.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Which Regional Markets are Lucrative for Manufacturers of Brain Monitoring Systems?
“Rising Clinical Studies for Advanced Brain Monitoring in North America Paving the Way for Suppliers of Brain Monitoring Devices”
In terms of market value, North America is anticipated to dominate the global market for brain monitoring systems, holding the highest market share. This is a result of both the availability of medical reimbursements and the increased prevalence of neurological diseases.
Demand for brain monitoring equipment in the region will rise as healthcare expenditure rises and the healthcare infrastructure improves.
Growing government funding for neuroscience has encouraged more clinical studies for cutting-edge brain monitoring technologies. The widespread availability of insurance coverage is another factor that has an impact on North America market expansion.
Asia Pacific is anticipated to lead the market from 2022 to 2027 due to several factors, including the increased prevalence of neurological and mental illnesses, the unmet demand for long-term treatment choices, and an increase in awareness campaigns.
Due to increased efforts being made by neurosurgeons and neurology clinics to promote knowledge about brain monitoring systems, the market for brain monitoring systems in the region is predicted to have excellent growth possibilities. Furthermore, the significant R&D investments made by international market competitors as a result of their low-cost structure are one of the key factors driving the market growth in the Asia Pacific region.
Country-wise Analysis
What is Boosting the Sales of Brain Monitoring Systems in the U.S.?
“Increasing Incidence of Neurological Conditions”
- 30 million people in the US are affected by 7,000 identified uncommon and ultra-rare disorders, according to the National Institute of Neurological Disorders and Stroke.
- Few have FDA-approved therapies, and many are life-threatening. 90% of rare children’s disorders have significant neurological repercussions, and about 45% of rare diseases, including ultra-rare diseases, are neurological abnormalities.
The prevalence of numerous neurodegenerative and neurological conditions is on the rise in the United States, which has prompted more advancements in mobile EEG technologies, real-time monitoring, and alarms. As a result, there is an increase in demand for brain monitoring products.
Why are Manufacturers of Brain Monitoring Systems Attracted to China?
“Rapid Adoption of Non-invasive Brain Monitoring Technologies & Presence of Highly Qualified Researchers”
Demand for brain monitoring machines in China is expected to increase at a high CAGR of 9% from 2022 to 2027 and reach US$ 2 billion by 2027.
Key players predict that China will be their preferred location for investment possibilities. It is because of the rapid increase in diagnoses, ongoing research, improvements in quality, and growing modernization of healthcare.
For instance, deep brain stimulators have long been used to treat neurological conditions such as Parkinson's disease. A device that acts as a form of pacemaker for the brain and electrically stimulates particular regions is placed during the process.
Where Western attempts to enhance deep brain stimulators for addiction trials on humans have failed, China is emerging as a hub for such research.
The brain monitoring products market is expanding in China as a result of an increase in the population of elderly people and patients with severe neurological diseases, rising investment in R&D, and the adoption of non-invasive brain monitoring technologies.
Category-wise Analysis
Which End User Accounts for High Consumption of Brain Monitoring Equipment?
“Significant Rise in Adoption of MRI & Standard EEG for Brain Monitoring in Hospitals”
Currently, hospitals are expected to hold a share of around 42% of the brain monitoring systems market. The complex process of brain monitoring calls for the utilization of pricey, cutting-edge equipment and systems that are often found in hospitals.
Furthermore, hospitals see a substantially bigger patient intake than small clinics and other end users. Also, the maintenance costs associated with brain monitoring equipment place a major financial burden on healthcare organizations, hospitals can bear such costs. As a result, hospitals make high use of brain monitoring systems.
Competitive Landscape
Major producers of brain monitoring devices are concentrating on marketing plans to broaden both their global footprint and product offering.
Brain monitoring device manufacturers also work with local and international players and form long-term alliances with ambulatory surgical centres, clinics, hospitals, and other distribution channels, including neonatal and paediatric ICUs.
Developments in Brain Monitoring Devices
- To enhance patient care, Medtronic and Rune Labs formed a collaboration in November 2021 to thoroughly investigate the effects of neurostimulation.
Brain Monitoring Devices Industry Research Segments
-
By Product:
- Devices
- Accessories
-
By Disease:
- Traumatic Brain Injuries
- Parkinson’s Disease
- Sleep Disorders
- Epilepsy
- Huntington’s Disease
- Headache Disorders
- Others
-
By End User:
- Hospitals
- Clinics
- Ambulatory Surgery Centers
- Neurological Centers
- Diagnostic Centers
- Others
-
By Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia & Oceania
- MEA
Table of Content
- 1. Global Market - Executive Summary
- 2. Global Market Overview
- 3. Market Risks and Trends Assessment
- 4. Market Background and Foundation Data Points
- 5. Global Market Demand (US$ Mn) Analysis 2017 to 2021 and Forecast, 2022 to 2027
- 6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2027, By Disease
- 6.1. Traumatic Brain Injuries
- 6.2. Parkinson’s Disease
- 6.3. Sleep Disorders
- 6.4. Epilepsy
- 6.5. Huntington’s Disease
- 6.6. Headache Disorders
- 6.7. Others
- 7. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2027, by Product
- 7.1. Devices
- 7.2. Accessories
- 8. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2027, by End User
- 8.1. Hospitals
- 8.2. Clinics
- 8.3. Ambulatory Surgery Centers
- 8.4. Neurological Centers
- 8.5. Diagnostic Centers
- 8.6. Others
- 9. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2027, by Region
- 9.1. North America
- 9.2. Latin America
- 9.3. Europe
- 9.4. East Asia
- 9.5. South Asia & Oceania
- 9.6. Middle East and Africa (MEA)
- 10. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2027
- 11. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2027
- 12. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2027
- 13. East Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2027
- 14. South Asia & Oceania Market Analysis 2017 to 2021 and Forecast 2022 to 2027
- 15. Middle East and Africa Market Analysis 2017 to 2021 and Forecast 2022 to 2027
- 16. Market Structure Analysis
- 17. Competition Analysis
- 17.1. Advanced Brain Monitoring
- 17.2. B. Braun Medical BD
- 17.3. Cadwell Industries Inc.
- 17.4. CAS Medical Systems Inc.
- 17.5. Compumedics Limited
- 17.6. DePuy Synthes Companies
- 17.7. Electrical Geodesics Inc
- 17.8. Elekta AB
- 17.9. EMOTIV Inc.
- 17.10. General Electric
- 17.11. Integra LifeSciences Corporation
- 17.12. Koninklijke Philips N.V.
- 17.13. Masimo Corporation
- 17.14. Medtronic
- 17.15. Natus Medical Incorporated
- 17.16. NIHON KOHDEN CORPORATION
- 17.17. Rimed Inc.
- 17.18. Siemens Healthcare Private Limited
- 17.19. Yokogawa Electric Corporation
- 18. Assumptions And Acronyms Used
- 19. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 1: Global Market Value (US$ Mn) Analysis, by Disease, 2017 to 2021
Table 2: Global Market Value (US$ Mn) Analysis, by Disease, 2022 to 2027
Table 3: Global Market Value (US$ Mn) Opportunity Analysis, by Disease, 2022 to 2027
Table 4: Global Market Value (US$ Mn) Analysis, by Product, 2017 to 2021
Table 5: Global Market Value (US$ Mn) Analysis, by Product, 2022 to 2027
Table 6: Global Market Value (US$ Mn) Opportunity Analysis, by Product, 2022 to 2027
Table 7: Global Market Value (US$ Mn) Analysis, by End User, 2017 to 2021
Table 8: Global Market Value (US$ Mn) Analysis, by End User, 2022 to 2027
Table 9: Global Market Value (US$ Mn) Opportunity Analysis, by End User, 2022 to 2027
Table 10: Global Market Value (US$ Mn) Analysis, by Region, 2017 to 2021
Table 11: Global Market Value (US$ Mn) Analysis, by Region, 2022 to 2027
Table 12: Global Market Value (US$ Mn) Opportunity Analysis, by Region, 2022 to 2027
Table 13: North America Market Value (US$ Mn) Analysis, by Country, 2017 to 2021
Table 14: North America Market Value (US$ Mn) Analysis, by Country, 2022 to 2027
Table 15: North America Market Value (US$ Mn) Opportunity Analysis, by Country, 2022 to 2027
Table 16: North America Market Value (US$ Mn) Analysis, by Disease, 2017 to 2021
Table 17: North America Market Value (US$ Mn) Analysis, by Disease, 2022 to 2027
Table 18: North America Market Value (US$ Mn) Opportunity Analysis, by Disease, 2022 to 2027
Table 19: North America Market Value (US$ Mn) Analysis, by Product, 2017 to 2021
Table 20: North America Market Value (US$ Mn) Analysis, by Product, 2022 to 2027
Table 21: North America Market Value (US$ Mn) Opportunity Analysis, by Product, 2022 to 2027
Table 22: North America Market Value (US$ Mn) Analysis, by End User, 2017 to 2021
Table 23: North America Market Value (US$ Mn) Analysis, by End User, 2022 to 2027
Table 24: North America Market Value (US$ Mn) Opportunity Analysis, by End User, 2022 to 2027
Table 25: Latin America Market Value (US$ Mn) Analysis, by Country, 2017 to 2021
Table 26: Latin America Market Value (US$ Mn) Analysis, by Country, 2022 to 2027
Table 27: Latin America Market Value (US$ Mn) Opportunity Analysis, by Country, 2022 to 2027
Table 28: Latin America Market Value (US$ Mn) Analysis, by Disease, 2017 to 2021
Table 29: Latin America Market Value (US$ Mn) Analysis, by Disease, 2022 to 2027
Table 30: Latin America Market Value (US$ Mn) Opportunity Analysis, by Disease, 2022 to 2027
Table 31: Latin America Market Value (US$ Mn) Analysis, by Product, 2017 to 2021
Table 32: Latin America Market Value (US$ Mn) Analysis, by Product, 2022 to 2027
Table 33: Latin America Market Value (US$ Mn) Opportunity Analysis, by Product, 2022 to 2027
Table 34: Latin America Market Value (US$ Mn) Analysis, by End User, 2017 to 2021
Table 35: Latin America Market Value (US$ Mn) Analysis, by End User, 2022 to 2027
Table 36: Latin America Market Value (US$ Mn) Opportunity Analysis, by End User, 2022 to 2027
Table 37: Europe Market Value (US$ Mn) Analysis, by Country, 2017 to 2021
Table 38: Europe Market Value (US$ Mn) Analysis, by Country, 2022 to 2027
Table 39: Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2022 to 2027
Table 40: Europe Market Value (US$ Mn) Analysis, by Disease, 2017 to 2021
Table 41: Europe Market Value (US$ Mn) Analysis, by Disease, 2022 to 2027
Table 42: Europe Market Value (US$ Mn) Opportunity Analysis, by Disease, 2022 to 2027
Table 43: Europe Market Value (US$ Mn) Analysis, by Product, 2017 to 2021
Table 44: Europe Market Value (US$ Mn) Analysis, by Product, 2022 to 2027
Table 45: Europe Market Value (US$ Mn) Opportunity Analysis, by Product, 2022 to 2027
Table 46: Europe Market Value (US$ Mn) Analysis, by End User, 2017 to 2021
Table 47: Europe Market Value (US$ Mn) Analysis, by End User, 2022 to 2027
Table 48: Europe Market Value (US$ Mn) Opportunity Analysis, by End User, 2022 to 2027
Table 49: East Asia Market Value (US$ Mn) Analysis, by Country, 2017 to 2021
Table 50: East Asia Market Value (US$ Mn) Analysis, by Country, 2022 to 2027
Table 51: East Asia Market Value (US$ Mn) Opportunity Analysis, by Country, 2022 to 2027
Table 52: East Asia Market Value (US$ Mn) Analysis, by Disease, 2017 to 2021
Table 53: East Asia Market Value (US$ Mn) Analysis, by Disease, 2022 to 2027
Table 54: East Asia Market Value (US$ Mn) Opportunity Analysis, by Disease, 2022 to 2027
Table 55: East Asia Market Value (US$ Mn) Analysis, by Product, 2017 to 2021
Table 56: East Asia Market Value (US$ Mn) Analysis, by Product, 2022 to 2027
Table 57: East Asia Market Value (US$ Mn) Opportunity Analysis, by Product, 2022 to 2027
Table 58: East Asia Market Value (US$ Mn) Analysis, by End User, 2017 to 2021
Table 59: East Asia Market Value (US$ Mn) Analysis, by End User, 2022 to 2027
Table 60: East Asia Market Value (US$ Mn) Opportunity Analysis, by End User, 2022 to 2027
Table 61: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2017 to 2021
Table 62: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2022 to 2027
Table 63: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Country, 2022 to 2027
Table 64: South Asia & Oceania Market Value (US$ Mn) Analysis, by Disease, 2017 to 2021
Table 65: South Asia & Oceania Market Value (US$ Mn) Analysis, by Disease, 2022 to 2027
Table 66: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Disease, 2022 to 2027
Table 67: South Asia & Oceania Market Value (US$ Mn) Analysis, by Product, 2017 to 2021
Table 68: South Asia & Oceania Market Value (US$ Mn) Analysis, by Product, 2022 to 2027
Table 69: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Product, 2022 to 2027
Table 70: South Asia & Oceania Market Value (US$ Mn) Analysis, by End User, 2017 to 2021
Table 71: South Asia & Oceania Market Value (US$ Mn) Analysis, by End User, 2022 to 2027
Table 72: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by End User, 2022 to 2027
Table 73: MEA Market Value (US$ Mn) Analysis, by Country, 2017 to 2021
Table 74: MEA Market Value (US$ Mn) Analysis, by Country, 2022 to 2027
Table 75: MEA Market Value (US$ Mn) Opportunity Analysis, by Country, 2022 to 2027
Table 76: MEA Market Value (US$ Mn) Analysis, by Disease, 2017 to 2021
Table 77: MEA Market Value (US$ Mn) Analysis, by Disease, 2022 to 2027
Table 78: MEA Market Value (US$ Mn) Opportunity Analysis, by Disease, 2022 to 2027
Table 79: MEA Market Value (US$ Mn) Analysis, by Product, 2017 to 2021
Table 80: MEA Market Value (US$ Mn) Analysis, by Product, 2022 to 2027
Table 81: MEA Market Value (US$ Mn) Opportunity Analysis, by Product, 2022 to 2027
Table 82: MEA Market Value (US$ Mn) Analysis, by End User, 2017 to 2021
Table 83: MEA Market Value (US$ Mn) Analysis, by End User, 2022 to 2027
Table 84: MEA Market Value (US$ Mn) Opportunity Analysis, by End User, 2022 to 2027
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 1: Global Market Value (US$ Mn) Historical Analysis, 2017 to 2021
Figure 2: Global Market Value (US$ Mn) Forecast and Analysis, 2022 to 2027
Figure 3: Global Market Value Y-o-Y Growth and Forecast, 2017 to 2027
Figure 4: Global Market Incremental $ Opportunity, 2022 to 2027
Figure 5: Global Market Share and BPS Analysis by Disease, 2022 & 2027
Figure 6: Global Market Y-o-Y Growth Projections by Disease, 2022 to 2027
Figure 7: Global Market Attractiveness Analysis by Disease, 2022 to 2027
Figure 8: Global Market Share and BPS Analysis by Product, 2022 & 2027
Figure 9: Global Market Y-o-Y Growth Projections by Product, 2022 to 2027
Figure 10: Global Market Attractiveness Analysis by Product, 2022 to 2027
Figure 11: Global Market Share and BPS Analysis by End User, 2022 & 2027
Figure 12: Global Market Y-o-Y Growth Projections by End User, 2022 to 2027
Figure 13: Global Market Attractiveness Analysis by End User, 2022 to 2027
Figure 14: Global Market Share and BPS Analysis by Region, 2022 & 2027
Figure 15: Global Market Y-o-Y Growth Projections by Region, 2022 to 2027
Figure 16: Global Market Attractiveness Analysis by Region, 2022 to 2027
Figure 17: North America Market Value (US$ Mn) Historical Analysis, 2017 to 2021
Figure 18: North America Market Value (US$ Mn) Forecast and Analysis, 2022 to 2027
Figure 19: North America Market Value Y-o-Y Growth and Forecast, 2022 to 2027
Figure 20: North America Market Incremental $ Opportunity, 2022 to 2027
Figure 21: North America Market Share Analysis by Country, 2022 & 2027
Figure 22: North America Market Y-o-Y Growth Projection by Country, 2022 to 2027
Figure 23: North America Market Attractiveness Analysis by Country, 2022 to 2027
Figure 24: North America Market Share and BPS Analysis by Disease, 2022 & 2027
Figure 25: North America Market Y-o-Y Growth Projections by Disease, 2022 to 2027
Figure 26: North America Market Attractiveness Analysis by Disease, 2022 to 2027
Figure 27: North America Market Share and BPS Analysis by Product, 2022 & 2027
Figure 28: North America Market Y-o-Y Growth Projections by Product, 2022 to 2027
Figure 29: North America Market Attractiveness Analysis by Product, 2022 to 2027
Figure 30: North America Market Share and BPS Analysis by End User, 2022 & 2027
Figure 31: North America Market Y-o-Y Growth Projections by End User, 2022 to 2027
Figure 32: North America Market Attractiveness Analysis by End User, 2022 to 2027
Figure 33: Latin America Market Value (US$ Mn) Historical Analysis, 2017 to 2021
Figure 34: Latin America Market Value (US$ Mn) Forecast and Analysis, 2022 to 2027
Figure 35: Latin America Market Value Y-o-Y Growth and Forecast, 2017 to 2027
Figure 36: Latin America Market Incremental $ Opportunity, 2022 to 2027
Figure 37: Latin America Market Share Analysis by Country, 2022 & 2027
Figure 38: Latin America Market Y-o-Y Growth Projection by Country, 2022 to 2027
Figure 39: Latin America Market Attractiveness Analysis by Country, 2022 to 2027
Figure 40: Latin America Market Share and BPS Analysis by Disease, 2022 & 2027
Figure 41: Latin America Market Y-o-Y Growth Projections by Disease, 2022 to 2027
Figure 42: Latin America Market Attractiveness Analysis by Disease, 2022 to 2027
Figure 43: Latin America Market Share and BPS Analysis by Product, 2022 & 2027
Figure 44: Latin America Market Y-o-Y Growth Projections by Product, 2022 to 2027
Figure 45: Latin America Market Attractiveness Analysis by Product, 2022 to 2027
Figure 46: Latin America Market Share and BPS Analysis by End User, 2022 & 2027
Figure 47: Latin America Market Y-o-Y Growth Projections by End User, 2022 to 2027
Figure 48: Latin America Market Attractiveness Analysis by End User, 2022 to 2027
Figure 49: Europe Market Value (US$ Mn) Historical Analysis, 2017 to 2021
Figure 50: Europe Market Value (US$ Mn) Forecast and Analysis, 2022 to 2027
Figure 51: Europe Market Value Y-o-Y Growth and Forecast, 2017 to 2027
Figure 52: Europe Market Incremental $ Opportunity, 2022 to 2027
Figure 53: Europe Market Share Analysis by Country, 2022 & 2027
Figure 54: Europe Market Y-o-Y Growth Projection by Country, 2022 to 2027
Figure 55: Europe Market Attractiveness Analysis by Country, 2022 to 2027
Figure 56: Europe Market Share and BPS Analysis by Disease, 2022 & 2027
Figure 57: Europe Market Y-o-Y Growth Projections by Disease, 2022 to 2027
Figure 58: Europe Market Attractiveness Analysis by Disease, 2022 to 2027
Figure 59: Europe Market Share and BPS Analysis by Product, 2022 & 2027
Figure 60: Europe Market Y-o-Y Growth Projections by Product, 2022 to 2027
Figure 61: Europe Market Attractiveness Analysis by Product, 2022 to 2027
Figure 62: Europe Market Share and BPS Analysis by End User, 2022 & 2027
Figure 63: Europe Market Y-o-Y Growth Projections by End User, 2022 to 2027
Figure 64: Europe Market Attractiveness Analysis by End User, 2022 to 2027
Figure 65: East Asia Market Value (US$ Mn) Historical Analysis, 2017 to 2021
Figure 66: East Asia Market Value (US$ Mn) Forecast and Analysis, 2022 to 2027
Figure 67: East Asia Market Value Y-o-Y Growth and Forecast, 2017 to 2027
Figure 68: East Asia Market Incremental $ Opportunity, 2022 to 2027
Figure 69: East Asia Market Share Analysis by Country, 2022 & 2027
Figure 70: East Asia Market Y-o-Y Growth Projection by Country, 2022 to 2027
Figure 71: East Asia Market Attractiveness Analysis by Country, 2022 to 2027
Figure 72: East Asia Market Share and BPS Analysis by Disease, 2022 & 2027
Figure 73: East Asia Market Y-o-Y Growth Projections by Disease, 2022 to 2027
Figure 74: East Asia Market Attractiveness Analysis by Disease, 2022 to 2027
Figure 75: East Asia Market Share and BPS Analysis by Product, 2022 & 2027
Figure 76: East Asia Market Y-o-Y Growth Projections by Product, 2022 to 2027
Figure 77: East Asia Market Attractiveness Analysis by Product, 2022 to 2027
Figure 78: East Asia Market Share and BPS Analysis by End User, 2022 & 2027
Figure 79: East Asia Market Y-o-Y Growth Projections by End User, 2022 to 2027
Figure 80: East Asia Market Attractiveness Analysis by End User, 2022 to 2027
Figure 81: South Asia & Oceania Market Value (US$ Mn) Historical Analysis, 2017 to 2021
Figure 82: South Asia & Oceania Market Value (US$ Mn) Forecast and Analysis, 2022 to 2027
Figure 83: South Asia & Oceania Market Value Y-o-Y Growth and Forecast, 2017 to 2027
Figure 84: South Asia & Oceania Market Incremental $ Opportunity, 2022 to 2027
Figure 85: South Asia & Oceania Market Share Analysis by Country, 2022 & 2027
Figure 86: South Asia & Oceania Market Y-o-Y Growth Projection by Country, 2022 to 2027
Figure 87: South Asia & Oceania Market Attractiveness Analysis by Country, 2022 to 2027
Figure 88: South Asia & Oceania Market Share and BPS Analysis by Disease, 2022 & 2027
Figure 89: South Asia & Oceania Market Y-o-Y Growth Projections by Disease, 2022 to 2027
Figure 90: South Asia & Oceania Market Attractiveness Analysis by Disease, 2022 to 2027
Figure 91: South Asia & Oceania Market Share and BPS Analysis by Product, 2022 & 2027
Figure 92: South Asia & Oceania Market Y-o-Y Growth Projections by Product, 2022 to 2027
Figure 93: South Asia & Oceania Market Attractiveness Analysis by Product, 2022 to 2027
Figure 94: South Asia & Oceania Market Share and BPS Analysis by End User, 2022 & 2027
Figure 95: South Asia & Oceania Market Y-o-Y Growth Projections by End User, 2022 to 2027
Figure 96: South Asia & Oceania Market Attractiveness Analysis by End User, 2022 to 2027
Figure 97: MEA Market Value (US$ Mn) Historical Analysis, 2017 to 2021
Figure 98: MEA Market Value (US$ Mn) Forecast and Analysis, 2022 to 2027
Figure 99: MEA Market Value Y-o-Y Growth and Forecast, 2017 to 2027
Figure 100: MEA Market Incremental $ Opportunity, 2022 to 2027
Figure 101: MEA Market Share Analysis by Country, 2022 & 2027
Figure 102: MEA Market Y-o-Y Growth Projection by Country, 2022 to 2027
Figure 103: MEA Market Attractiveness Analysis by Country, 2022 to 2027
Figure 104: MEA Market Share and BPS Analysis by Disease, 2022 & 2027
Figure 105: MEA Market Y-o-Y Growth Projections by Disease, 2022 to 2027
Figure 106: MEA Market Attractiveness Analysis by Disease, 2022 to 2027
Figure 107: MEA Market Share and BPS Analysis by Product, 2022 & 2027
Figure 108: MEA Market Y-o-Y Growth Projections by Product, 2022 to 2027
Figure 109: MEA Market Attractiveness Analysis by Product, 2022 to 2027
Figure 110: MEA Market Share and BPS Analysis by End User, 2022 & 2027
Figure 111: MEA Market Y-o-Y Growth Projections by End User, 2022 to 2027
Figure 112: MEA Market Attractiveness Analysis by End User, 2022 to 2027
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What is the predicted growth rate of the global brain monitoring devices market?
Worldwide sales of brain monitoring devices are expected to increase at a CAGR of 6% from 2022 to 2027.
What is the current market value for brain monitoring devices?
The global brain monitoring devices market is currently valued at US$ 6.5 billion.
What is the market predicted to be worth by 2027?
The global market for brain monitoring devices is projected to reach US$ 8.7 billion by 2027.
What is the China brain monitoring devices market size?
The market for brain monitoring devices in China is expected to balloon at 9% CAGR and reach a valuation of US$ 2 billion by 2027.
At what pace is the devices segment expected to expand?
The devices segment is predicted to progress at a CAGR of 6% through 2027.
Brain Monitoring Devices Market